271 related articles for article (PubMed ID: 23614975)
1. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
Nagel KN; Schouten MG; Hambrock T; Litjens GJ; Hoeks CM; ten Haken B; Barentsz JO; Fütterer JJ
Radiology; 2013 Apr; 267(1):164-72. PubMed ID: 23329653
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.
Somford DM; Hoeks CM; Hulsbergen-van de Kaa CA; Hambrock T; Fütterer JJ; Witjes JA; Bangma CH; Vergunst H; Smits GA; Oddens JR; van Oort IM; Barentsz JO;
Invest Radiol; 2013 Mar; 48(3):152-7. PubMed ID: 23328910
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Diffusion Weighted Imaging May Improve Risk Stratification of Prostatic Transition Zone Lesions.
Engel H; Oerther B; Reisert M; Kellner E; Sigle A; Gratzke C; Bronsert P; Krauss T; Bamberg F; Benndorf M
In Vivo; 2022; 36(5):2323-2331. PubMed ID: 36099133
[TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
6. MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland.
Panda A; Obmann VC; Lo WC; Margevicius S; Jiang Y; Schluchter M; Patel IJ; Nakamoto D; Badve C; Griswold MA; Jaeger I; Ponsky LE; Gulani V
Radiology; 2019 Sep; 292(3):685-694. PubMed ID: 31335285
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
8. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
[TBL] [Abstract][Full Text] [Related]
9. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
[TBL] [Abstract][Full Text] [Related]
10. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.
Li C; Chen M; Wan B; Yu J; Liu M; Zhang W; Wang J
Acta Radiol; 2018 Nov; 59(11):1395-1402. PubMed ID: 29486596
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
13. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.
Yu AC; Badve C; Ponsky LE; Pahwa S; Dastmalchian S; Rogers M; Jiang Y; Margevicius S; Schluchter M; Tabayoyong W; Abouassaly R; McGivney D; Griswold MA; Gulani V
Radiology; 2017 Jun; 283(3):729-738. PubMed ID: 28187264
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
[TBL] [Abstract][Full Text] [Related]
15. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.
Bittencourt LK; Barentsz JO; de Miranda LC; Gasparetto EL
Eur Radiol; 2012 Feb; 22(2):468-75. PubMed ID: 21913058
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
18. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
[TBL] [Abstract][Full Text] [Related]
19. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
